Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

Melanie Z Sakatis; Melinda J Reese; Andrew W Harrell; Maxine A Taylor; Ian A Baines; Liangfu Chen; Jackie C Bloomer; Eric Y Yang; Harma M Ellens; Jeffrey L Ambroso

doi:10.1021/tx300075j

Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

Identifier:nobleid.org/w1/20260515/ABC6EBED

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ABC6EBED.svg?ark=w1%2F20260515%2FABC6EBED)](https://nobleid.org/work/w1/20260515/ABC6EBED)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

Identifier:nobleid.org/w1/20260515/ABC6EBED

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ABC6EBED.svg?ark=w1%2F20260515%2FABC6EBED)](https://nobleid.org/work/w1/20260515/ABC6EBED)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work